OMBLASTYS (OMBURTAMAB) Trademark

Trademark Overview


On Friday, April 24, 2020, a trademark application was filed for OMBLASTYS (OMBURTAMAB) with the United States Patent and Trademark Office. The USPTO has given the OMBLASTYS (OMBURTAMAB) trademark a serial number of 88886712. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by Y-mAbs Therapeutics, Inc. The OMBLASTYS (OMBURTAMAB) trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer

Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
omblastys (omburtamab)

General Information


Serial Number88886712
Word MarkOMBLASTYS (OMBURTAMAB)
Filing DateFriday, April 24, 2020
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6338259
Registration DateTuesday, May 4, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements


Indication of Colors claimedThe color(s) teal, purple, light green, and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"OMBURTAMAB"
Description of MarkThe mark consists of the stylized, capitalized, purple word "OMBLASTYS" with three stacked V-shapes emanating from the top of the letter "Y", with the first in purple, the second in light green, and the third in teal. Centered beneath the word "OMBLASTYS", in all lower-case letters, in a different font, and in parentheses, is the word "OMBURTAMAB" in gray.
Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Goods and ServicesResearch and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameY-mAbs Therapeutics, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Party NameY-mAbs Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Party NameY-mAbs Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Trademark Events


Event DateEvent Description
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 27, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 21, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, August 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 20, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 17, 2020ASSIGNED TO LIE
Wednesday, July 29, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, July 24, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 24, 2020LETTER OF SUSPENSION E-MAILED
Friday, July 24, 2020SUSPENSION LETTER WRITTEN
Monday, July 20, 2020EXAMINER'S AMENDMENT ENTERED
Monday, July 20, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 20, 2020EXAMINERS AMENDMENT E-MAILED
Monday, July 20, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, July 17, 2020ASSIGNED TO EXAMINER
Thursday, May 7, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 28, 2020NEW APPLICATION ENTERED IN TRAM